Adenocarcinoma of the Esophagogastric Junction

Among malignant tumors, adenocarcinomas of the esophagogastric junction show the highest increase in incidence over the past three decades in Western industrialized countries. Accordingly, much effort is being devoted to basic and translational research in order to combat this frequently deadly dise...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Schneider, Paul M. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2010.
Edición:1st ed. 2010.
Colección:Recent Results in Cancer Research, 182
Temas:
Oncology.
Internal medicine.
Respiratory organs > Diseases.
Internal Medicine.
Pneumology.
Acceso en línea:Texto Completo
Tabla de Contenidos:
  • Epidemiology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third
  • Clinical Classification Systems of Adenocarcinoma of the Esophagogastric Junction
  • Histopathologic Classification of Adenocarcinoma of the Esophagogastric Junction
  • The Pathogenesis of Barrett's Metaplasia and the Progression to Esophageal Adenocarcinoma
  • Differences in the Molecular Biology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third
  • Clinical Staging of Adenocarcinoma of the Esophagogastric Junction
  • Endoscopic Mucosal Resection for Staging and Therapy of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third
  • Surgical Strategies for Adenocarcinoma of the Esophagogastric Junction
  • Current Status of Sentinel Lymph Node Biopsy in Adenocarcinoma of the Distal Esophagus, Gastric Cardia, and Proximal Stomach
  • Current Diagnosis and Future Impact of Micrometastases for Therapeutic Strategies in Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third
  • Quality Indicators of Surgery for Adenocarcinoma of the Esophagus and Gastroesophageal Junction
  • Peri-Operative and Complication Management for Adenocarcinoma of the Oesophagus and Oesophagigastric Junction
  • Multimodality Therapy for Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third
  • Metabolic Response Evaluation by PET During Neoadjuvant Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction
  • Molecular Response Prediction in Multimodality Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction.

Ejemplares similares